Leap Therapeutics, Inc. (LPTX) NASDAQ
0.77
-0.02500003(-3.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 76.72M |
| Enterprise Value | 62.73M |
| P/E Ratio | -3.52 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.37 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.05 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.65 |
| Return On Equity | -0.47 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -36.54M |
| Net Income | 4.82M |
| Diluted EPS | 0.07 |
Balance Sheet
| Total Cash | 6.69M |
| Total Cash/Share | 0.04 |
| Total Debt | 38,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 27.28 |
| Book Value Per Share | 0.5 |
Price History
| 52-Week Change | 85.36 |
| 52-Week High | 3.58 |
| 52-Week Low | 0.22 |
| Moving Average 50 Days | 0.71 |
| Moving Average 200 Days | 0.45 |
Statistics
| Average Volume | 26.09M |
| Shares Outstanding | 41.39M |
| % Held by Institutions | 11.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 21, 2023 |
